The independent source for health policy research, polling, and news.
401 - 420 of 15,455 Results
California Gov. Gavin Newsom vetoed a bill that would have expanded access to hormone therapy, a top priority for the trans community. Advocates say it would have ensured continuity in gender-affirming care amid Trump administration attacks. Analysts say it’s another sign of the Democrat’s move to the center.
States are battling for their piece of $50 billion in federal rural health funding, but it’s not just hospitals vying for the money. Tech startups and policy demands are raising the stakes as Medicaid cuts loom.
Democrats and Republicans remain stalled over funding the federal government as Republicans launch a new attack on the Affordable Care Act. Meanwhile, the Trump administration is taking advantage of the shutdown to lay off workers from programs supported mostly by Democrats. Anna Edney of Bloomberg News, Lauren Weber of The Washington Post, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine join KFF Health News’ Julie Rovner to discuss those stories and more. Also this week, Rovner interviews health insurance analyst Louise Norris about Medicare open enrollment.
As families fracture, people are living longer and are more likely to find themselves without close relatives or friends at the end of their lives.
The idea that airplane vapors are toxic to people or that there are ongoing efforts to intentionally change the climate made the social media rounds. Now, it has found advocates at the Department of Health and Human Services.
The health secretary’s statement doesn’t consider the impact that the Medicaid cuts advanced in the same law will have on health care in rural America.
In Mississippi, a state with one of the highest obesity rates in the nation, Medicaid covers weight loss drugs, but few enrollees have signed up for the benefit.
Jessica Altman, the head of California’s Affordable Care Act health insurance marketplace, warns letters will be sent out this week with sky-high premiums unless Washington extends covid-era enhanced tax credits by then. Even if Congress acts later and rates are lower than feared, she says, shoppers could be scared off.
More men are now living long enough to develop osteoporosis. But few are aware of the risk, and fewer still are screened and treated.
Environmental and economic concerns prompt some people to explore obsequies options beyond metal caskets and cremation.
KFF Health News journalists made the rounds on national media recently to discuss topical stories. Here’s a collection of their appearances.
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
As contractors position themselves to cash in on a gush of new business managing Medicaid work requirements, a cadre of senators has launched an inquiry into the companies paid billions to build eligibility systems.
President Donald Trump called the Digital Equity Act unconstitutional, racist, and illegal. Then the $2.75 billion program for rural and underserved communities to gain internet access disappeared.
Ketamine, long used as an anesthetic or illegal party drug, is being combined with psychotherapy to treat severe depression and post-traumatic stress — a potential tool for those with high trauma rates, like firefighters and police officers. Yet the drug’s stigma and unregulated marketplace leave first responders in uncharted territory.
The government shutdown continues with no end in sight, and while it theoretically should not affect entitlement programs, the lapse of some related authorizations — like for Medicare telehealth programs — is leaving some doctors and patients high and dry. Meanwhile, the FDA quietly approved a new generic abortion pill. Sarah Karlin-Smith of Pink Sheet, Tami Luhby of CNN, and Alice Miranda Ollstein of Politico join KFF Health News’ Julie Rovner to discuss those stories and more. Also, Rovner interviews Sarah Grusin of the National Health Law Program.
On the "Today, Explained" podcast, KFF Health News' Julie Rovner recaps the TrumpRx announcement and why the direct-to-consumer initiative may not save you money on prescription drugs if you have insurance through your employer or the government.
Biomedical researchers and patients are caught in the middle as the Trump administration continues its campaign to strip grants from universities accused of bias. Courts have restored some frozen funds to California universities, but academics studying brain tumors, lung cancer, and strokes worry their grant dollars remain a bargaining chip.
California’s nursing shortage is projected to worsen, and hospitals say funding cuts will only add strain. But front-line nurses blame heavy workloads, not a shortage, for driving workers away.
© 2026 KFF